ACT Activated clotting time
ADP Adenosine diphosphate
AHA Acquired haemophilia A
aPTT Activated partial thromboplastin time
AUC Area under the curve
BU Bethesda unit
CEM Clot elastic modulus
CHAMP CDC Hemophilia A Mutation Project
CHBMP CDC Hemophilia B Mutation Project
CR Clot rate
DIC Disseminated intravascular coagulation
dRVVT  Diluted Russell viper venom time
dNTPs  Deoxyribonucleotide triphosphates
ddNTPs  Dideoxynucleotides
ED Exposure day
ELISA Enzyme-linked immunosorbent assay
ETP Endogenous thrombin potential
F Factor
FDA Food and Drug Administration
FVII CD FVII congenital deficiency
FXIII CD FXIII congenital deficiency
GIDH Glutamate dehydrogenase
GP Glycoprotein
GT Glanzmann's thrombasthenia
HA Haemophilia A
HB Haemophilia B
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
HIS Heparin Insensitive
HIV Human immunodeficiency virus
HLA Human leucocyte antigen
HRP Horseradish peroxidase
HMWK  High molecular weight kininogen
HwI Haemophilia with inhibitors
Ig Immunoglobulins
INR International normalised ratio
ISI International sensitivity index
ISTH International Society on Thrombosis and Haemostasis
ITGA2B Integrin subunit alpha 2b
ITGB3 Integrin subunit beta 3
K Clot formation time
KCT Kaolin clotting time
LA Lupus anticoagulant
LTA Light transmission aggregometry
MA Maximal clot firmness
MASAC Medical and Scientific Advisory Council
MNPT Mean normal prothrombin time
NADPH Nicotinamide adenine dinucleotide phosphate
PA Peak amplitude
PCR Polymerase chain reaction
PCF Platelet contractile force
PF3 Platelet factor 3
PFA Platelet function analysis
PIVKA Protein induced by vitamin K absence/antagonist-II
PLPs Phospholipids
pNA para-nitroaniline
PNP Platelet neutralisation procedure
PPP Platelet-poor plasma
PRP Platelet-rich plasma
PT Prothrombin time
R Clotting time
Rco Ristocetin cofactor
ROTEG Rotational thromboelastography
ROTEM Rotational thromboelastometry
RTF Recombinant tissue factor
RUO Research use only
RVV Russel viper venom
RVVT Russel viper venom time
SCT Sonoclot analysis
SCT Silica clotting time 
sTF Soluble tissue factor
TF Tissue factor
TEG Thromboelastography
TEM Thromboelastometry
TGA Thrombin generation assay
TGT Thrombin generation time
TRAP Thrombin receptor activating protein
TEM Thromboelastometry
vW von Willebrand
vWD von Willebrand disease
vWF von Willebrand factor
WFH World Federation of Hemophilia
WHO World Health Organisation
HQMMA/CH/0217/0024; HQMMA/CH/0916/0170; HQMMA/NNG/0517/0163; HQMMA/NNG/0517/0164; HQMMA/NNG/0517/0165; HQMMA/NNG/0517/0166; HQMMA/NNG/0517/0167